Back
GraniteShares 2x Short NVDA Daily ETF Vs. Zenas BioPharma, Inc. Industry Stock Comparison
Sell
50
NVD
GraniteShares 2x Short NVDA Daily ETF
Last Price:
$9.62
Seasonality Move:
-44.32%
Sell
29
ZBIO
Zenas BioPharma, Inc.
Last Price:
$35.81
Seasonality Move:
0.59%
Sell
50
GraniteShares 2x Short NVDA Daily ETF (NVD)
is a Sell
Is GraniteShares 2x Short NVDA Daily ETF a Buy, Sell or Hold?
-
The current GraniteShares 2x Short NVDA Daily ETF [NVD] share price is $9.63. The Score for NVD is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
NVD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
29
Zenas BioPharma, Inc. (ZBIO)
is a Sell
Is Zenas BioPharma, Inc. a Buy, Sell or Hold?
-
The current Zenas BioPharma, Inc. [ZBIO] share price is $35.81. The Score for ZBIO is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
ZBIO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NVD Stock Price Chart
What is GraniteShares 2x Short NVDA Daily ETF's stock price today?
-
The GraniteShares 2x Short NVDA Daily ETF share price today is $9.63Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVD is experiencing buying pressure, which is a positive indicator for future bullish movement.
ZBIO Stock Price Chart
What is Zenas BioPharma, Inc.'s stock price today?
-
The Zenas BioPharma, Inc. share price today is $35.81Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZBIO is experiencing slight selling pressure.
NVD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.2 | Buy |
| Relative Strength Index (14 RSI): | 62.18 | Buy |
| Chaikin Money Flow: | 23175782 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.19 - 9.03) | Buy |
| Bollinger Bands (100): | (8.16 - 9.94) | Buy |
ZBIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.86 | Buy |
| Relative Strength Index (14 RSI): | 49.55 | Sell |
| Chaikin Money Flow: | -89322 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.22 - 39.36) | Sell |
| Bollinger Bands (100): | (17.16 - 33.88) | Buy |
NVD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.8 | Buy |
| 20-day SMA: | 8.73 | Buy |
| 50-day SMA: | 8.41 | Buy |
| 200-day SMA: | 15.64 | Sell |
| 8-day EMA: | 8.98 | Buy |
| 20-day EMA: | 8.72 | Buy |
| 50-day EMA: | 8.75 | Buy |
| 200-day EMA: | 22.54 | Sell |
ZBIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.84 | Sell |
| 20-day SMA: | 37.69 | Sell |
| 50-day SMA: | 32.84 | Buy |
| 200-day SMA: | 17.75 | Buy |
| 8-day EMA: | 7.96 | Buy |
| 20-day EMA: | 3.41 | Buy |
| 50-day EMA: | 1.4 | Buy |
| 200-day EMA: | 0.36 | Buy |
GraniteShares 2x Short NVDA Daily ETF Earnings Growth & NVD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.65 per share, and an increase next year of $0.59 per share.
GraniteShares 2x Short NVDA Daily ETF Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Zenas BioPharma, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||